Clinical Trials Directory

Trials / Conditions / Leukaemia

Leukaemia

12 registered clinical trials studyying Leukaemia — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingStudy of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.
NCT07518329
Arovella Therapeutics LtdPhase 1
RecruitingEBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
NCT07410676
Essen BiotechPhase 1 / Phase 2
Not Yet RecruitingA Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokin
NCT07296445
SDK Therapeutics, Inc.Phase 3
RecruitingxDRIVE for Florida-based Cancer Patients
NCT07167381
First Ascent Biomedical Inc.N/A
RecruitingRandomised Controlled Trial of Artificial Intelligence-assisted Health Education
NCT07305337
Zhongnan HospitalN/A
UnknownBenchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)
NCT05473325
Willows Health—
TerminatedFirst in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid
NCT03594955
SanofiPhase 1 / Phase 2
RecruitingPUMA (Paediatric Osseous Marrow Assessment)
NCT03466944
Institute of Cancer Research, United Kingdom—
CompletedHigh Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant
NCT01941680
University Hospital Center of Martinique—
TerminatedMyloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT)
NCT02310997
University College, LondonPhase 2
CompletedOfatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia
NCT01313689
Novartis PharmaceuticalsPhase 3
CompletedPhase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML
NCT00502385
AstraZenecaPhase 1